PubMed:17151160 / 1149-1385 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T12","span":{"begin":0,"end":236},"obj":"Sentence"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-entities","denotations":[{"id":"3680","span":{"begin":19,"end":30},"obj":"DiseaseOrPhenotypicFeature"},{"id":"3681","span":{"begin":45,"end":55},"obj":"ChemicalEntity"},{"id":"3682","span":{"begin":66,"end":77},"obj":"ChemicalEntity"},{"id":"3683","span":{"begin":178,"end":188},"obj":"ChemicalEntity"},{"id":"3684","span":{"begin":224,"end":235},"obj":"ChemicalEntity"}],"attributes":[{"id":"A21","pred":"db_id","subj":"3680","obj":"MESH:D015430"},{"id":"A22","pred":"db_id","subj":"3681","obj":"MESH:C076029"},{"id":"A23","pred":"db_id","subj":"3682","obj":"MESH:D018967"},{"id":"A24","pred":"db_id","subj":"3683","obj":"MESH:C076029"},{"id":"A25","pred":"db_id","subj":"3684","obj":"MESH:D018967"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":95,"end":106},"obj":"GeneOrGeneProduct"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T9","span":{"begin":95,"end":106},"obj":"GeneOrGeneProduct"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T8","span":{"begin":19,"end":30},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"originalLabel","subj":"T8","obj":"D015430"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":95,"end":106},"obj":"GeneOrGeneProduct"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T9","span":{"begin":19,"end":30},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"D015430"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T9","span":{"begin":19,"end":30},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"#label","subj":"T9","obj":"D015430"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T25","span":{"begin":45,"end":55},"obj":"ChemicalEntity"},{"id":"T27","span":{"begin":66,"end":77},"obj":"ChemicalEntity"},{"id":"T29","span":{"begin":178,"end":188},"obj":"ChemicalEntity"},{"id":"T31","span":{"begin":224,"end":235},"obj":"ChemicalEntity"}],"attributes":[{"id":"A25","pred":"ID:","subj":"T25","obj":"D000077152"},{"id":"A26","pred":"ID:","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A27","pred":"ID:","subj":"T27","obj":"D018967"},{"id":"A28","pred":"ID:","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A29","pred":"ID:","subj":"T29","obj":"D000077152"},{"id":"A30","pred":"ID:","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A31","pred":"ID:","subj":"T31","obj":"D018967"},{"id":"A32","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T31","span":{"begin":224,"end":235},"obj":"ChemicalEntity"},{"id":"T29","span":{"begin":178,"end":188},"obj":"ChemicalEntity"},{"id":"T27","span":{"begin":66,"end":77},"obj":"ChemicalEntity"},{"id":"T25","span":{"begin":45,"end":55},"obj":"ChemicalEntity"},{"id":"T78543","span":{"begin":95,"end":106},"obj":"GeneOrGeneProduct"},{"id":"T17021","span":{"begin":19,"end":30},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A32","pred":"ID:","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A31","pred":"ID:","subj":"T31","obj":"D018967"},{"id":"A30","pred":"ID:","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A29","pred":"ID:","subj":"T29","obj":"D000077152"},{"id":"A28","pred":"ID:","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_8871"},{"id":"A27","pred":"ID:","subj":"T27","obj":"D018967"},{"id":"A26","pred":"ID:","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_7735"},{"id":"A25","pred":"ID:","subj":"T25","obj":"D000077152"},{"id":"A31263","pred":"#label","subj":"T17021","obj":"D015430"}],"text":"Significantly more weight gain occurred with olanzapine than with risperidone: the increase in weight at 4 months relative to baseline weight was 17.3% (95% CI=14.2%-20.5%) with olanzapine and 11.3% (95% CI=8.4%-14.3%) with risperidone."}